PMC7682475_01
Effect of tocilizumab on inflammatory markers. IL-6, interleukin-6; CRP, C-reactive protein.
CRIN2020-8829309.001.jpg
PMC7682475_01_CRIN2020-8829309.001.jpg
fig1
His inflammatory markers such as C-reactive protein (CRP), IL-6, and ferritin were significantly elevated (Figure 1).
Chest X-ray AP view showing extensive bilateral perihilar and basal opacities on day 2 (a), which has improved significantly by day 4 as shown in (b).
CRIN2020-8829309.002.jpg
PMC7682475_01_CRIN2020-8829309.002.jpg
fig2
On day 4, significant improvement occurred as shown by decreased breathlessness, decreased support of NIV and O2 requirements, and improvement in the bilateral chest infiltrates as demonstrated by chest X-ray (Figure 2).